Navigation Links
Senetek PLC Reports Second Quarter 2008 Financial Results
Date:8/14/2008

Cash on Hand Totals $17.8 million at June 30

Investor Conference Call Scheduled for September 5

NAPA, Calif., Aug. 14 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today announced financial results for the quarter ended June 30, 2008.

Revenue for the quarter ended June 30, 2008 was $691,000, compared with $471,000 reported in the second quarter of 2007.

Net income for the quarter ended June 30, 2008 totaled $257,000, or $0.03 per share compared to a net loss of $397,000 a loss of $0.05 per share in the second quarter of 2007. Net income for the quarter ended June 30, 2008 included other income of $1,125,000 from the previously announced settlement with Triax Aesthetics LLC and a service provider.

Cash and cash equivalents totaling $17,803,000, or $2.33 per share at June 30, 2008 represent the resources necessary to meet operating requirements for the foreseeable future.

Senetek's Board of Directors will meet on August 28, 2008. Matters to be addressed include a capital restructure to facilitate both a possible share buyback and dividend program and a Nominating Committee review of Board candidates.

Senetek will conduct a teleconference call for investors on Friday, September 5, 2008 at 9:00 a.m. Pacific, 12:00 p.m. Eastern to provide an update to include:

* Pyratine-6(TM) -- current success in U.S. physician market and Q4 2008

launch plan.

* Invicorp(R) EU -- effect of Ardana Bioscience Ltd. insolvency.

* Invicorp(R) US -- Plethora Solutions Ltd. report on status of regulatory

pathway.

* Reliaject(R) -- update on Ranbaxy's progress.

* Corporate and Product Public Relations.

The domestic dial-in number is 877-593-8638; the international dial-in number is 706-634-9240, conference ID 60464120. Mr. Frank J.
'/>"/>

SOURCE Senetek PLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Senetek PLC Reports First Quarter 2008 Financial Results
2. Senetek PLC Announces Appointments of Key Personnel
3. Senetek PLC in Dispute With Marketer of Pyratine-6(TM)
4. Cadus Reports Second Quarter 2008 Results
5. Huifeng Bio-Pharmaceutical (HFGB) Reports over $5 Million in Gross Sales; Record Results for the First Half of 2008
6. China Bio Energy Holdings Group Reports Second Quarter 2008 Financial Results
7. Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
8. Derma Sciences Reports Second Quarter 2008 Results
9. Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results
10. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
11. NeurogesX Reports Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... -- The National Necrotizing Fasciitis Foundation (NNFF) ... doctors at Vanderbilt University Hospital in Nashville, ... Dr. John Crew , director of the ... in Daly City, CA. ... by Dr. Crew, that had previously saved the lives ...
(Date:8/27/2015)... , August 27, 2015 GlassesOff ... image processing functions in the human vision system, announced today ... point guard Chris Paul to develop a ... who want to improve their real-life on-court performance. ... court, whether it is shooting a ball or blocking a ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... presented new data on the relationship of genetics and hypertension at the ... Heart Disease in Vancouver, British Columbia, Canada. The event, which boasts an extensive ...
(Date:8/26/2015)... ... August 26, 2015 , ... Lee Biosolutions, ... the development and manufacture of highly valued cardiac markers used in early detection ... expertise with protein chemistry has led to the development and commercialization of important ...
Breaking Biology Technology:Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 3Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2
... -- Prodesse, Inc. announced Monday that it ... completed a major process improvement to its ProFlu-1 assay. ... core investors, plus three new accredited individuals, have provided ... of a debt instrument convertible into equity at increasing ...
... knows that men and women truly are different. , ,Social ... come to the fore: around 80 percent of all autism ... differ greatly between the sexes - just about everyone agrees ... human development, critical brain proteins known as steroid receptors lay ...
... UW E-Business Consortium member spotlight series. Sub-Zero Freezer Company ... , ,People who are passionate about food tend ... consumers turn to is Madison, Wis.-based Sub-Zero Freezer Co. ... integrated to match a home's dcor, allowing customization to ...
Cached Biology Technology:Prodesse gets new funding; improves flu assay 2Gender hormones may lend to social disorder therapies 2How Sub-Zero Freezer Co. uses technology to revolutionize customer service 2How Sub-Zero Freezer Co. uses technology to revolutionize customer service 3
(Date:8/4/2015)... Research and ... addition of the "Digital Forensics Market ... (Computer Forensics, Network Forensics, Mobile Device Forensics, ... and Region - Global Forecast to 2020" ... By Component (Hardware, Software, and Service), Sub-Segment ...
(Date:7/31/2015)... -- Den 10. internationale konference om Genomik (ICG-10, ... 25. oktober i Shenzhen , Kina. ... år. Siden starten i 2006 er ICB blevet en ... er en af de mest dynamiske, entusiastiske og sjove ... gennembrud og fremskridt inden for ,omik,-forskning, som yderligere vil ...
(Date:7/31/2015)... 2015 La 10e Conférence internationale sur ... par le BGI du 22 au 25 octobre ... Chine. La conférence célèbre son 10e ... l,ICG est devenue l,une des réunions annuelles mondiales ... et c,est aussi la plus dynamique, la plus ...
Breaking Biology News(10 mins):Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3
... COLUMBIA, Mo. About one in 3,500 people are ... retina,s visual cells that eventually leads to blindness. Now, ... link between cats and humans for two different forms ... therapies that will benefit both cats and humans. ...
... As researchers continue to examine the role ... people understand the differences among various ingredients used ... Association (CRA). Interchanging two distinctly different ingredients, such ... creates factually incorrect conclusions and misleads ,consumers. ...
... BEER-SHEVA, ISRAEL, March 4, 2009 Ben-Gurion University of ... plutonium created in large nuclear reactors, making it unsuitable ... (Am 241), a form of the basic synthetic element ... can only be used for peaceful purposes. , This ...
Cached Biology News:Cats' eye diseases genetically linked to diseases in humans 2Pure fructose frequently confused with high fructose corn syrup 2Ben-Gurion University engineers develop technique to help combat nuclear proliferation 2
... immunostaining ,This solution has effect on enhancing ... clearer signal than the one obtained by ... of secondary antibody used and exposure time ... have images with high S/N ratio and ...
AVOID FREEZE/THAW CYCLES. Recognizes the UCP-2 protein....
... (eIF4E-binding protein II) is involved in translation ... kidney. PHAS proteins bind to eIF-4E, the ... capped mRNA in vitro and in cells. ... of PHAS/eIF-4E complexes. This allows eIF-4E to ...
Human GCP-2 is a member of the CXC family of chemokines. It also promotes neutrophil chemotaxis and deganulation. GF063 is an 8.0 kDa protein containing 73 amino acid residues....
Biology Products: